Koninklijke Philips NV

Royal Philips has priced an offering of EUR 650 million fixed rate notes due 2034 under its European Medium Term Note program. The notes are the healthcare industry's first EU Green Bond under the new European Green Bond Standard. The issue price is 99.655% with a coupon of 4.0%, yielding 4.055%, and the 7.8 year tranche was oversubscribed by 2.7 times. Proceeds will finance taxonomy-aligned economic activities supporting Philips' 2030 Impact Ambition. Settlement is scheduled for August 28, 2026, with listing on the Luxembourg Stock Exchange.

Cofoe Medical and Philips launched a strategic cooperation project at the 19th Xipu Conference, titled "Philips home health measurement devices empower the upgrade of China's health stations," to accelerate the rollout of pharmacy health services. Since reaching a strategic partnership in December 2025, the two sides have integrated Philips' cutting-edge health smart technologies with Cofoe Medical's localized R&D, manufacturing, and channel operation capabilities to drive AI technology into home health scenarios. The Philips smart health solution released this time uses home health measurement devices as the entry point, a dedicated home health management app as the digital foundation, and an AI health assistant as the core enabler, helping residents build electronic health records covering key indicators such as blood pressure, blood glucose, blood oxygen, body temperature, and body composition. It also provides pharmacies with practical tools for health testing, chronic disease management, health consultation, and refined member operations. Cofoe Medical Vice President Yu Xiangyu said that health stations aim to help pharmacies transform from one-time transaction venues into sustainably operated community health service nodes.

Koninklijke Philips announced new collaborations to expand its open monitoring ecosystem and connected care offerings, including the launch of the Philips Avent Share the Care Connector to support postpartum mothers with digital tools and guidance. The company is working with health technology partners to extend continuous and out-of-hospital patient monitoring capabilities, integrating third-party wearables and platforms into its existing ecosystem such as the Patient Information Center iX. The Share the Care Connector was launched in collaboration with March of Dimes, focusing on maternal health support through SMS tools and behavioral insights from the March of Dimes survey. Philips is a €23.2 billion medical equipment and health technology company focused on connected care solutions across North America, Greater China, and other international markets.

Royal Philips announced new collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree, and smartQare to expand its open patient monitoring ecosystem. The partnerships integrate wearable and out-of-hospital technologies into the Philips ecosystem, supporting continuous patient visibility from hospital to home. Products include TempTraq for core body temperature, VitalStream for non-invasive blood pressure, Cuviva’s hospital-at-home platform, UbiqVue multiparameter biosensor, Respiree’s cardio-respiratory monitoring, and viQtor & Healthdot biosensors. These additions complement Philips’ broader connected care portfolio, including Mobile Cardiac Telemetry for remote cardiac monitoring up to 30 days post-discharge. The initiative aims to help health systems improve continuity and coordination of care across the care continuum.

The global AI in medical imaging market is projected to grow from USD 2.9 billion in 2025 to USD 19.4 billion by 2035, at a compound annual growth rate of 20.9%, according to a new report by Healthcare Foresights. The market is expected to reach USD 3.5 billion in 2026, driven by a shortage of radiologists, high imaging volumes, and the need for faster clinical decision-making. Key growth factors include advancements in deep learning algorithms, increasing adoption of digital health technologies, and supportive regulatory approvals for AI-powered tools. North America is forecast to grow at a CAGR of 16.7%, while the Asia Pacific region is experiencing the highest growth due to rapid digital health transformation and expanding medical imaging infrastructure. Prominent players in the market include GE HealthCare Technologies, Siemens Healthineers, Koninklijke Philips, and Canon Medical Systems.

Philips reiterated its full-year comparable sales growth outlook of 3% to 4.5% and updated its reported free cash flow guidance to between 1.5 billion and 1.7 billion euros, incorporating a U.S. tariff refund recognized in the second quarter. CEO Roy Jakobs said second-quarter comparable sales rose 4%, while CFO Charlotte Hanneman noted the adjusted EBITA margin increased to 16.4% including the tariff benefit, with an underlying margin of 12.2% excluding it. The company now expects a full-year adjusted EBITA margin of 13.5% to 14% including the refund, up from the underlying range of 12.5% to 13%. Order intake declined 1% as certain larger monitoring orders moved to the third quarter, but management expects solid order growth in the third quarter and highlighted a record equipment order book. For the third quarter, comparable sales growth is expected at the lower end of the full-year range due to China and Ultrasound, with adjusted EBITA margin below the prior-year level.

Philips has raised its earnings outlook after receiving $158 million in US tariff refunds, recovering almost all of the duties it had paid. Director General Roy Jakobs said the company was among the first to apply for the refund following a US Supreme Court ruling that struck down most of President Trump's tariffs. The refund helped Philips report better-than-expected second-quarter profit margins, with net profit rising to 386 million euros from 240 million euros a year earlier. Quarterly sales reached 4.4 billion euros, and the group maintained its annual revenue growth forecast of 3 to 4.5 percent. Philips continues to face legal proceedings over its recalled DreamStation sleep apnoea devices, having reached a $1.1 billion settlement in the US last year without admitting liability.

The global electrophysiology market is projected to grow from USD 12.89 billion in 2025 to USD 43.05 billion by 2035, at a compound annual growth rate of 12.79%, according to a new report by SNS Insider. Ablation catheters held the largest product segment share at 46.82% in 2025, while pulse field ablation is the fastest-growing segment with a CAGR of 17.64%. North America led the market with a 42.37% revenue share in 2025, and the Asia Pacific region is expected to grow the fastest at a 14.44% CAGR through 2035. Key companies include Abbott Laboratories, Medtronic, Johnson & Johnson MedTech, Boston Scientific, and Philips Healthcare.

United Imaging Intelligence, an AI-focused subsidiary of Chinese medical technology giant Shanghai United Imaging Healthcare, is taking a cautious approach to deploying AI tools, resisting pressure for an aggressive rollout. Co-CEO Zhou Xiang, speaking on the sidelines of the World Artificial Intelligence Conference, said the company is not that extreme, noting that software engineers and architects warned him about potential side effects because the technology remains insufficiently mature. He added that in healthcare and medicine, the first mover advantage is not as drastic as in other fields. The United Imaging group competes with GE HealthCare, Siemens Healthineers and Philips in medical imaging and scanning equipment.

HealthTrust Performance Group announced AirLife, Philips, American Express and CSL Behring as recipients of its 2026 Supplier of the Year Awards. The awards will be presented at the annual HealthTrust University Conference on July 21 in Denver, Colorado. AirLife was named Medical-Surgical Supplier of the Year for its financial value and supply continuity efforts. Philips received the Capital Supplier of the Year award for optimizing financial and operational performance. American Express was recognized as Commercial Supplier of the Year for its corporate card and B2B payment solutions. CSL Behring earned Pharmacy Supplier of the Year for reliable access to plasma-derived therapies and innovative contracting strategies.

Philips has launched its Alturion ultrasound system with AI-powered workflows for high-volume clinical settings. The system is now available in the U.S. and Europe after receiving FDA 510(k) clearance and CE mark certification. Alturion combines advanced imaging with AI-driven automation to streamline examinations and support consistency across users, featuring a 24-inch monitor and a compact design for easy movement between departments and bedside. It includes Elevate Plus for AI-powered abdominal measurements and is compatible with Collaboration Live for real-time remote support. Alturion shares a common user interface and interchangeable transducers with Philips' EPIQ Elite and Affiniti systems as part of its connected ultrasound ecosystem.

The global neonatal infant care market is projected to grow from USD 3.84 billion in 2025 to USD 8.94 billion by 2035, at a compound annual growth rate of 7.9 percent. Thermoregulation devices, including incubators and radiant warmers, held the largest product segment share in 2025 due to their critical role in preventing hypothermia in premature infants. North America led the market, supported by advanced healthcare infrastructure and a high concentration of Level III and IV NICUs, while the Asia Pacific region is expected to see the fastest growth driven by high preterm birth rates and expanding healthcare investments. Key players include GE HealthCare Technologies, Drägerwerk, Philips Healthcare, Natus Medical, and Fisher & Paykel Healthcare. Recent developments include Dräger Medical's launch of the BabyRoo TN 300 open warmer with enhanced thermoregulation and monitoring features.

University Health in San Antonio has entered a long-term strategic contract with Royal Philips to modernize and standardize patient monitoring across its growing public health system. The agreement adopts Philips' Enterprise Monitoring as a Service model, transitioning the health system to a fully integrated Philips monitoring platform that includes the Central Monitoring Unit for continuous remote telemetry, IntelliVue bedside monitors, and the Patient Information Center for unified data and clinical decision support. The platform is designed to improve alarm management, support data-driven care, and provide a scalable foundation for future innovation. University Health Chief Operating Officer Bill Phillips said the investment reflects the system's commitment to safe, high-quality care supported by modern technology.

The Walt Disney Company and Omnicom announced a new collaboration between Omnicom Media and Disney Advertising to implement a connected TV ad solution enabling dynamic sequential storytelling across video on demand and live programming. The partnership, set to be announced at Cannes Lions, is already live in the United States and will expand to Europe and Latin America later this year. The solution integrates Disney's identity graph, Acxiom's identity capabilities, Omni's measurement platform, and Innovid's creative sequencing technology to replace repetitive streaming ads with personalized storytelling. In a separate development, Disney and Royal Philips announced on May 28 the incorporation of Disney animated characters into Philips Ambient Experience for MRI at medical facilities in 87 countries to support children undergoing imaging procedures.

The global healthcare command centers market is projected to grow from USD 1.8 billion in 2024 to USD 5.0 billion by 2034, at a compound annual growth rate of 10.8%, according to a new report from Zion Market Research. The software component segment held a 48% share in 2024, while the cloud-based deployment mode accounted for 49% of the market. North America led with a 41% share, driven by advanced healthcare infrastructure and technology adoption. Key players include GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, and Oracle (Cerner).

Philips has introduced the IntelliVue Patient Monitor 6000 Series, a full monitoring solution designed to bring enterprise-grade capabilities to rural hospitals, ambulatory surgery centers, and other U.S. healthcare segments at an affordable price. The series features core measurements built into a self-contained, one-piece design, along with two innovations debuting in this portfolio: the IntelliVue Measurement Rack 6000, which uses IntelliVue modules to expand monitoring beyond built-in parameters, and new Flexible Link technology, a first for Philips monitors, allowing plug-and-play measurement expansion after the point of sale through two connectors on each model. The monitors run the same IntelliVue software as the MX line for fast clinical adoption and cybersecurity, and offer scalable connectivity from standalone use to direct EMR integration via HL7 outbound or enterprise-wide integration within the Philips ecosystem. Ajay Parkhe, Business Leader for Hospital Patient Monitoring at Philips, said the PM 6000 Series helps ease pressure on healthcare organizations with flexible, high-quality monitoring in an affordable, scalable solution.